丢丢
Lv21
130 积分
2023-07-20 加入
-
Population Pharmacokinetics of Xeligekimab: An Anti-IL-17A Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis
4小时前
已完结
-
基于药代动力学数据建模的PK相关研究中采血点选取策略研究
2个月前
已完结
-
Applying the Noninferiority Paradigm to Assess Exposure-Response Similarity and Dose Between Pediatric and Adult Patients
2个月前
已关闭
-
度普利尤单抗注射液儿科临床研究对我国儿童用药研发的启示
2个月前
已完结
-
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
-
Maurer et al, GA²LEN Global Urticaria Forum; Berlin, December 6, 2022
4个月前
已关闭
-
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients with Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia
5个月前
已完结
-
The Role of OX40–OX40L Axis in the Pathogenesis of Atopic Dermatitis
11个月前
已关闭
-
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials
1年前
已完结
-
Baseline eosinophil level may be a predictive indicator for the effectiveness of Dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study in China
1年前
已完结